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Abstract 
Background: The simultaneous occurrence of cerebellopontine angle (CPA) meningioma 
and vestibular schwannoma (VS) in the absence of neurofibromatosis type 2 or history of 
irradiation is very rare. We report a case with coexistent CPA meningioma and VS, which 
were radiologically not distinguishable in preoperative imaging.  
Case Description: A 46-year-old female presented with acute hearing loss, tinnitus and 
gait ataxia. Otorhinolaryngological diagnostic workup and imaging studies showed an 
intra- and extrameatal homogenous contrast enhancing lesion. The neuroradiological 
diagnosis was VS. The patient was operated via the retrosigmoid approach. 
Intraoperatively two distinct tumors were found: a small, mainly intrameatally located VS 
and a larger meningioma originating from the dura of the petrous bone. Both tumors 
were completely microsurgically removed. The patient experienced no new neurological 
deficit after surgery; particularly facial nerve function was completely preserved. 
Histopathological examination revealed a fibromatous meningioma and a VS, 
respectively.  
Conclusions: The coincidental occurrence of CPA meningioma and VS is very rare. 
Careful interpretation of imaging studies before surgery is crucial. Even such rare cases 
should be kept in mind when discussing the therapeutic options with the patient. More  
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studies are needed for a better understanding of mechanisms leading to multiple tumor 
growth. 
 
Introduction 
Meningioma and vestibular schwannoma (VS) are the most and second most common 
intracranial benign tumors. In the cerebellopontine angle (CPA) these tumors comprise 
6–15% [1, 2] and 80% [1, 3, 4], respectively, of all tumors. While the occurrence of these 
brain tumors in one patient is well known in phakomatoses, as for example in 
neurofibromatosis type 2 (NF-2), or with a history of previous irradiation of the brain [5, 
6], it is a very rare condition without these circumstances. There are few published cases 
in the literature reporting intracranial meningioma combined with schwannoma in the 
same patient [6, 7], and only 5 cases of meningioma and VS in the same CPA are reported 
(table 1). 
In the present paper, a case of coexisting CPA meningioma and VS on the left side in a 
46-year-old woman, who was operated in our department, is reported. The literature of 
previous reported cases of meningioma associated with schwannoma in the absence of 
NF-2 is reviewed and possible proposed mechanisms leading to the development of two 
different tumor types in one patient are discussed. 
Case Report 
A 46-year-old woman presented to the department of Otorhinolaryngology and Head and Neck 
Surgery with a history of acute hearing loss and intermittent tinnitus on her left side as well as slight gait 
ataxia for several weeks. Pure tone audiometry and speech discrimination score showed left-sided 
deafness and normal hearing on the right side. Electronystagmography revealed reduced excitability of 
the left vestibular organ. Neurological examination was unremarkable except for deafness on the left ear 
and a slight gait ataxia. There were no clinical cutaneous signs pointing to the diagnosis of NF-2. The 
family history for NF-2 was also unremarkable. After the clinical workup was finished, MRI and CT 
imaging of the cerebrum were performed. 
MRI of the brain with and without gadolinium contrast showed a homogenous contrast-enhancing 
tumor in the internal auditory meatus with extension in the CPA. The tumor portion in the CPA 
showed broad attachment to the dura of the petrous bone. There were no differences in contrast 
enhancement of the tumor (fig. 1). CT scan showed a widening of the internal auditory canal and no 
calcifications within the tumor (fig. 1). The neuroradiological diagnosis was intra- and extrameatal VS. 
After the neuroradiological diagnosis of a VS was established, the patient was transferred to the 
neurosurgical department to be operated via the lateral suboccipital approach because of the large 
extrameatal tumor growth. 
A lateral suboccipital craniectomy on the left side was performed, the cerebellomedullar cistern was 
opened, the cerebellum retracted and finally the CPA exposed under the operating microscope. It 
revealed two distinct tumors, a small VS and a meningioma with clear broad attachment to the dura of 
the petrous bone. The meningioma was located a little above and anterior of the VII and VIII cranial 
nerves. Both tumors could be completely removed under neurophysiological monitoring. The 
postoperative course of the patient was uneventful, the patient showed no new neurological deficit after 
surgery; particularly facial nerve function was completely preserved (House and Brackmann grade I). 
The patient could be discharged home on the sixth postoperative day. 
Histopathological workup of both tumor samples confirmed the diagnosis of fibromatous 
meningioma and VS, respectively (fig. 2, 3). 
MR imaging studies performed 3 months after surgery showed complete removal of both tumors 
and no signs of tumor recurrence.  
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Discussion 
VSs are benign intracranial tumors that originate from Schwann cells along the 
vestibular portion of the eighth cranial nerve. They represent approximately 10% of all 
intracranial tumors and more than 80% of CPA tumors [3, 4]. Meningiomas arise from 
the dural coverings of the brain and are the most common benign intracranial tumors, 
accounting for 13–26% of all primary intracranial tumors [8]. They comprise 
approximately 10–15% of all CPA tumors [1]. 
Multiple primary brain tumors are common in patients with phakomatoses, such as 
NF-2 [9, 10]. NF-2 is an autosomal dominant inherited disease with an incidence of less 
than 1 in 25,000 people [11]. The diagnosis of NF-2 is made clinically, and the current 
diagnostic criteria for NF-2 are met when an individual has either characteristic bilateral 
VSs or a first-degree relative with NF-2 and one of the following: a unilateral VS before 
the age of 30 years or the presence of 2 tumors (neurofibroma, meningioma, glioma, 
schwannoma, or juvenile posterior subcapsular lenticular opacity) [3, 12]. Furthermore, 
the pathogenetic mutation in the NF-2 gene on chromosome 22 can be identified by 
genetic testing [13]. 
VSs in NF-2 patients more commonly show a lobular pattern, a higher cellularity, and 
an association with meningeal proliferation. In contrast, unilateral VSs infrequently 
display a lobular pattern, normally have lower cellularity and abnormal vasculature, and 
are not associated with meningiomas [3]. 
There are also some reports in the recent literature of so-called mixed tumors in NF-2 
patients, meaning the co-existence of meningioma and schwannoma as two distinct 
histological components within the same tumor [3, 10]. A previous history of irradiation 
is another well-known cause for the development of multiple primary brain tumors [3, 
14]. 
Our patient has had no family history and no clinical or radiological signs of 
neurofibromatosis, although the patient was not tested genetically for NF-2. There was 
also no history of irradiation. 
The occurrence of two separate histologically different tumors in one patient in the 
absence of the above mentioned conditions is extremely rare [5]. There are to our 
knowledge only 5 cases in the literature describing meningioma and VS occurring 
together in the same CPA [15–19] (table 1). In most of these cases, the preoperative 
radiological imaging already revealed the presence of two distinct tumors, either because 
the tumors were located clearly distant of each other and showed the typical radiological 
signs of either meningioma or VS, or because of different contrast enhancement patterns 
[16, 18, 19]. VSs invade and expand the acoustic canal, tend to be more regular in 
appearance and are internally less homogenous. Meningiomas are implanted 
asymmetrically on the internal auditory canal with an irregular external surface and show 
broad contact with the skull base, along the petrous bone, or the tentorium. The internal 
auditory canal is not widened, and tumoral tissue rarely extends into the internal auditory 
canal. Internal contrast enhancement is usually uniform. Calcification and cystic changes 
are frequent [18]. 
In the presented case, the radiological differentiation of two separate tumors had not 
been possible before surgery. Our neuroradiologists described the tumor as a VS, since 
there was a widening of the internal auditory canal and a clear intrameatal contrast 
enhancement. No differentiation could be made by means of the character of contrast 
enhancement. No calcifications were seen on imaging studies.  
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Surgery clearly revealed two distinct tumors in the left CPA: a small, mainly 
intrameatally located VS and a larger meningioma, located a little anterior and above, 
with broad contact to the dura of the petrous bone. These findings were confirmed by 
histopathological examination. The large tumor was found to be a fibrous meningioma 
with typical features (fig. 2a); the small intrameatal tumor was classified as a schwannoma 
with histopathologically typical Antoni A and Antoni B areas (fig. 2b). Tibor Pap silver 
stain showed the typical fine fiber reticulin network in VS tissue, but not in meningioma 
tissue (not shown). 
Immunohistochemical studies showed clearly positive immunoreactivity for vimentin 
and epithelial membrane antigen (EMA) in fibrous meningioma, whereas it did not in VS. 
Furthermore, immunohistochemical stain revealed S-100 protein positive cells in 
schwannoma tissue and only a weak positive reaction in meningioma tissue (fig. 3). 
Preservation rates and predicting factors for preservation of hearing and facial nerve 
function are also different in VSs and meningiomas [20]. Hearing preservation rates are 
usually higher after removal of a CPA meningioma because of the extradural origin of 
meningiomas [2]. The chance of preserving the facial nerve depends on the tumor size, 
the topographical relationship between tumor and facial nerve, and preoperative facial 
nerve function [20]. 
Radiosurgery is an alternative treatment option particularly for smaller VSs not 
compressing the brainstem or causing hydrocephalus [21]. Selectivity of radiosurgery 
depends on the biological differences in the response of different tissues [21], for example 
concerning tumor regression, which is most common with schwannomas [21], or the role 
of fractionated radiation therapy [22]. 
The above mentioned facts stress the importance of establishing a correct radiological 
diagnosis before offering surgery or radiosurgery to the patient, and of giving the patient 
the best counseling concerning the risks of both treatment options. 
There have been several theories trying to explain the coincidence of two completely 
separate primary brain tumors in the absence of conditions like phakomatoses or 
previous brain irradiation: (1) tumors can develop entirely coincidentally; (2) the initial 
tumor can act as a stimulus on the surrounding cerebral parenchyma or meningeal tissue 
to induce a new tumor in a different tissue; (3) a carcinogenic stimulus may develop 
tumors in different tissues simultaneously; or (4) a residual embryonic structure becomes 
the basis for subsequent multiple brain tumor development [5]. Furthermore, Tsukamoto 
et al. [6] discussed the association of meningioma and neurinoma, which could be 
determined genetically, since the genes responsible for the occurrence of these tumors are 
both located on chromosome 22. However, Tsukamoto et al. did not perform a gene 
analysis in their patient. This theory could also be true for our patient. 
Finally, we suggest that the combination of a CPA meningioma and a VS occurred 
most likely incidentally. However, the influence of some tumor growth factor forcing the 
second tumor to grow is theoretically possible in our case, since the tumors were located 
nearby in the same CPA. More research on possible mechanisms has to be done to 
support this theory. 
In conclusion, meningioma and VS may very rarely occur coincidentally in the same 
CPA. These tumors can usually be safely and completely removed with a single surgical 
suboccipital approach. Preoperative imaging studies should be read carefully to establish 
the diagnosis of two different tumors in order to plan the surgical procedure and to offer 
the best treatment plan to the patient. The very rare cases of two different primary brain  
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tumors which lie adjacent to each other and which are not distinguishable on 
preoperative imaging must also be kept in mind when counseling the patient about the 
risks of the surgical procedure. 
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Table 1. Summary of previously reported cases of coexistent CPA meningioma and VS 
Author Year  Tumor 
side 
Age/ 
Sex 
Radiological differentiation of two distinct 
tumors on preoperative imaging studies 
Gardner and Turner [15]  1939  Left  48/F  Not possible (only Roentgenograms available) 
Thomassin et al. [17]  1991  Right  64/F  Not possible 
Wilms et al. [18]  1992  Right  47/F  Possible 
Chandra and Hedge [19]  2000  Right  35/F  Possible 
Izci et al. [16]  2007  Left  57/F  Possible 
Present case  2010  Left  46/F  Not possible 
 
 
 
 
Fig. 1. Axial (a) and coronal (b) T1-weighted gadolinium-enhanced MR images showing a 
homogeneous contrast-enhancing intrameatal (arrow) and extrameatal (arrowhead) tumor in the left 
CPA. Native bone window CT scan (c) shows widening of the left internal auditory canal (arrow) and 
no calcifications within the tumor. 
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Fig. 2. a Hematoxylin-eosin staining showing the typical patterns of a fibromatous meningioma with 
central clearing (ĹĻ) and psammoma body (**). b Hematoxylin-eosin staining showing the typical 
features of a VS with Antoni A (A) and Antoni B (B) areas. 
 
 
 
Fig. 3. Immunohistochemical studies showing a clearly positive reaction for vimentin in the 
meningioma (a) and, for the most part, a negative immunoreactivity for vimentin in the VS (b); a 
pronounced diffuse-positive reaction for epithelial membrane antigen (EMA) in the meningioma (c) 
and a negative reaction for EMA in the VS (d); a for the most part negative immunoreactivity for S-100 
in the meningioma (e) and a clearly positive reaction for S-100 immunohistochemistry in the VS (f). 
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